Skip to main content
Premium Trial:

Request an Annual Quote

Michael Olex, George Haas, Kate Bingham, and Paul Woloshin


Michael Olex has been named vice president, manufacturing at BioTrove.

Olex will oversee the construction of BioTrove’s 10,000 sq. ft. manufacturing facility for production of the first product in its Living Chip microfluidics platform, the company said. Prior to his appointment, Olex served as senior vice president, manufacturing and operations at US Genomics, and has held senior executive positions at PerSeptive Biosystems, now owned by Applied Biosystems.

Olex holds BS and MS degrees in electrical engineering from the University of Detroit and Cleveland State University, respectively, said BioTrove. He also earned an MBA from Case Western Reserve University.

George Haas has been appointed to the supervisory board of Ingenium Pharmaceuticals. Haas replaces Kate Bingham, general partner of Schroder Ventures Life Sciences, who stepped down at the end of 2003.

Most recently, Haas served as worldwide head of pharmaceutical development at Ciba-Geigy, where he was employed for 27 years.

He received his PhD in chemistry from the Federal Institute of Technology in Zurich, and completed his postdoctoral training at Cornell University. He also completed management training at Harvard Business School.

Paul Woloshin has been appointed executive director of the Oregon Biosciences Association. Woloshin will lead OBA in its mission to support and expand Oregon’s bioscience community, both commercial and academic, the organization said.

Woloshin most recently held the position of director of finance and administration for the Oregon Health and Science University Research Division.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.